Author Archives: Jeremy Bentham

Greenslit article comment

Nathan Greenslit challenges us to think about our relationships with pharmaceuticals. I didn’t think the article was just about consumption and branding, but rather identity practices that place the reader/consumer in a state of being. This state of being may … Continue reading

Posted in Uncategorized | Leave a comment

Comment on “Ready-to-Recruit” or “Ready-to-Consent” Populations?

A good introductory piece by Jill Fisher, and too much to comment on in 250 words. I’ve decided to focus on the significance of recruitment times and the state of accrual. In the clinical trial context, meeting accrual targets is … Continue reading

Posted in Uncategorized | Leave a comment

Summary on Clinical Trials in Practice II: Contract Research

Clinical Trials in Practice II: Contract Research  “The Contract Research Organization and the Commercialization of Scientific Research” 2005. Philip Mirowski and Robert Van Horn provide their own perspective, as a response to competing views, on the introduction and rise of … Continue reading

Posted in Uncategorized | Leave a comment

RCT comment

The Grossman and Mackenzie piece brings forward an important discussion regarding the dominance of randomized controlled trials (RCTs). There is certainly enough recent evidence to suggest that academic and industry research overly emphasizes the reliability. But I was a bit … Continue reading

Posted in Uncategorized | Leave a comment

Comment on Thick Prescriptions

Oldani’s piece on pharmaceutical sales tactics was not that surprising given what has been discussed in class thus far, but one thing that struck me was how similar the tactics are to other sales industries. I suppose the exception would … Continue reading

Posted in Uncategorized | Leave a comment

Comment on Conflict of Interest

Thompson’s piece on “Understanding Financial Conflicts of Interest” raises some interesting questions about conflict of interest in a clinical trial setting. What happens if there is no financial benefit for an investigator? Is that even possible? And is a conflict … Continue reading

Posted in Uncategorized | Leave a comment

Jeremy R. Simon article comment

Jeremy R. Simon’s article, “Constructive Realism and Medicine: an approach to medical ontology”, provides an opening for potential future understandings of evolving singular-model accounts. This was not the primary focus of his article, but the concept of multiple-models/diseases is an … Continue reading

Posted in Uncategorized | Leave a comment